In this issue:
ELF score reliable for assessing advanced fibrosis in NALFD
Comparative efficacy of therapies for fibrosis improvement and resolution of NASH
Liver disease associated with higher mortality and morbidity than heart failure or COPD
Lower risk of death linked to UDCA response in primary biliary cholangitis with cirrhosis
Liver injury at hospitalisation associated with severity of COVID disease
Do patients with chronic liver disease have an increased risk of COVID-19-related death?
Long-term follow-up of INF-α treatment for HBeAg-positive chronic HBV infection
Identification of novel immunologic markers of viral hepatitis-related HCC risk
Entecavir and tenofovir both efficacious for HCC prevention in HBV patients
Real-world efficacy of salvage triplet SOF/VEL/VOX regimen for HCV
Please login below to download this issue (PDF)